Analystreport

Cytosorbents (NASDAQ:CTSO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.

Cytosorbents Corporation  (CTSO) 
Last cytosorbents corporation earnings: 11/5 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: cytosorbents.com